SRCM
TTOO

Signature Resources Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Signature Resources Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-90
Closed -$565 – 450
2024
Q1 		$565 Hold
90
– – ﹤0.01% 373
2023
Q4 		$565 Buy
+90
New +$688 ﹤0.01% 374

Other funds holding TTOO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Signature Resources Capital Management's TTOO Position: Q2 2024 in Review

Signature Resources Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q2 2024, closing a stake of 90 shares — an estimated $565 sold.

Signature Resources Capital Management first reported a position in TTOO in Q4 2023 and held it in 2 quarters. The position peaked at $565 in Q1 2024. 21 funds tracked by Wall St. Rank hold TTOO as of Q2 2024.

  • Signature Resources Capital Management reported no remaining T2 Biosystems, Inc position as of Q2 2024 after selling out during the quarter.
  • Signature Resources Capital Management sold 90 T2 Biosystems, Inc shares in Q2 2024, an estimated $565.
  • Signature Resources Capital Management first reported a position in T2 Biosystems, Inc in Q4 2023 and held it in 2 quarters.
  • Signature Resources Capital Management's T2 Biosystems, Inc position peaked at $565 in Q1 2024.
  • 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2024.

Based on Signature Resources Capital Management's 13F filing for Q2 2024, filed 18 Jul 2024.